We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
28.00 | 9.33% | 328.00 | 325.50 | 330.00 | 350.00 | 303.00 | 304.00 | 1,285,192 | 16:35:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -6.95 | 313.89M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/5/2024 21:30 | in 2024 trust the "experts" or trust our chaps :(77% differential) :) nai | takeiteasy | |
04/5/2024 10:10 | Happy international StarWars day everybody. May the 4th be with you and all that. OXB try to avoid 3rd parties for recruitment. You can see what they are looking for at any particular time via that link on their website 11 at the moment. Kingzog wins the prize for getting post 7777. | harry s truman | |
04/5/2024 07:50 | Has anyone here still been topping up since we headed above 3 quid...someone must have been buying :) | takeiteasy | |
04/5/2024 07:31 | ''The scope of recruitment will include from junior to director level roles.'' | mirabeau | |
04/5/2024 07:29 | OXB embarking on a hiring spree for numerous roles, from 'toilet cleaner' to Director. Expansion no doubt in expectation of volume led work as per ''Build Talent Pools for specific high volume roles'' : Talent Acquisition (Recruitment) Specialist Oxford BioMedica (UK) Limited OXFORD Salary - To define Start date - 3 May 2024 Closing date - 31 May 2024 Job description: We are currently recruiting for a Talent Acquisition Specialist to join the Human Resources team, initially for a 12 month fixed term contract. The purpose of this role is to partner closely with assigned senior level stakeholders, acting as an advisor and taking ownership for the end-to-end recruitment lifecycle, from recruitment briefing meeting, advertising, sourcing, arranging interviews and making job offers, negotiating and agreeing final packages. The scope of recruitment will include from junior to director level roles. Your responsibilities in this role would be: For assigned roles, you will manage the end-to-end recruitment process. This includes: Conduct a Recruitment Briefing Meeting with the Hiring Manager to ensure an understanding of the requirements of the vacancy and the interview process, providing guidance on the current candidate market place Source Develop job adverts to post and advertise vacancies Search and ‘headhunt&rsqu Build Talent Pools for specific high volume roles Promote the Employee Referral program and encourage internal development and movement Advertise on LinkedIn and JobBoards, promoting the Employee Value Proposition cont...... | mirabeau | |
03/5/2024 14:34 | On for one million shares traded on a Friday before a May Bank holiday with a 10% rising share price. Not bad? | gareth jones | |
03/5/2024 13:42 | US Payrolls missed, rate cut probability increased, indices rally. | mirabeau | |
03/5/2024 13:28 | No doubt about it. America are buying in having been left out earlier in the day. | dominiccummings | |
03/5/2024 12:49 | I must say Harry that it's worth holding OXB just to get an education on what's going on in the pharmacy sector. Keep up the good work! | ygor705 | |
03/5/2024 12:41 | We now have a high quality problem on our hands. I liken the recent movement in the share price to starting a very big fire at a tyre factory viz it is very visible and will attract attention from miles around. This could push the spike here quite high but it will then be interesting to see if a sudden fall sucks in more buyers. I seem to remember comment that shares were being issued at c.£4 at the time of the French acquisition: perhaps that a good starting point for genuine current share price value. | ygor705 | |
03/5/2024 12:32 | I have no idea what is going on either, but it does remind me of a time when buying a few SCI at 270p, seeing them go to 330p. It was an illiquid stock and when a forced seller appeared, the MM's walked the price down to <50p. Once the seller dumped the final tranche, the price moved upwards rapidly almost hitting 700p. | strapittoyourankle | |
03/5/2024 12:28 | i would like to thank Harry for his posts.i am now back in profit having been looking at a big loss. Without those well informed posts i probably would have lost the faith. | edwardt | |
03/5/2024 11:56 | Is there more to this than a lovely set of results - if this was always worth 4-5 on worst case Harry, why did it ever get so low...I find this whole episode very odd. Perhaps it is simply the RR type scenario when the market gets too down on a great business? back into an auction - unbelievable :) | takeiteasy | |
03/5/2024 11:54 | Wowza.... looking great.:) | kumala | |
03/5/2024 11:27 | There has being a lot of pain watching the decline of OXB price over the last while. My smile is widening by the minute... think we are all entitled to some sunshine . Enjoy | connello | |
03/5/2024 11:18 | After the half year results, IM bought aggressively as part of their stated aim to get to 10% and that took the price rapidly to £3. As we know, they may not actually need to buy any more in the market to get to 10% once the EUR20m shares are issued later in the year. It could be, if they are not currently inside on anything, that they have taken the view to aim to go beyond 10%? They were very clear before on their aims, but I don't think they'd need to announce any change to that in advance? | cousinit | |
03/5/2024 11:16 | Well done all 🍒🍒 | linton5 | |
03/5/2024 11:06 | I'm intrigued to know what's driving this | mirabeau | |
03/5/2024 10:50 | AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEN | blackhorse23 | |
03/5/2024 10:36 | I think we're all assuming OXB does the one step back at some point, but so far on the Friday of a bank holiday weekend when I'd normally expect a slow day - no sign of it. FTSE quarterly review is the end of this month. 580p+ would be back in the FT250 and all sins forgiven. I honestly wasn't expecting that so soon after the results, but similarly if it did happen by some circumstance of events (like whatever is causing this movement and / or the insiders not buying) then it wouldn't surprise me either. | harry s truman | |
03/5/2024 10:27 | I bet that DB note's been circulating for a few weeks, no wonder the price took off mid-April | mirabeau | |
03/5/2024 10:24 | They want their clients to get in first :) | takeiteasy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions